Cidara Therapeutics (CDTX) said Thursday it has promoted Nicole Davarpanah to chief medical officer.
Davarpanah was most recently a clinical and translational lead at Genentech/Roche, Cidara said.
The company said it also promoted Corrina Pavetto to the role of senior vice president for clinical development.
Shares of Cidara gained more than 5% in recent trading activity.
Price: 22.11, Change: +1.23, Percent Change: +5.87
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。